Interestingly, a study by Kallioniemi and colleagues looking at RB1 loss in clinical breast cancer samples by fluorescent in situ hybridisation showed that most of the cells within these tumours contained two copies of the RB1 gene even when they showed LOH by restriction fragment length polymorphism at the RB1 locus [59]. Here, RB1 is linked to breast carcinoma.